Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sedana Medical ABOSTO:SEDANA -1.01%69 Current Ratio is 2.89 as of Jun. 2026, which is 70% below its 10-year median of 9.50. GuruFocus rates OSTO:SEDANA with a GF Score™ of 69/100 and a GF Value™ of kr17.42 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Sedana Medical AB ranks better than 56.62% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sedana Medical AB's current ratio for the quarter that ended in Jun. 2026 was 2.89.
Sedana Medical AB has a current ratio of 2.89. It generally indicates good short-term financial strength.
The historical rank and industry rank for Sedana Medical AB's Current Ratio or its related term are showing as below:
OSTO:SEDANA'
s Current Ratio Range Over the Past 10 Years
Min: 0.95 Med: 9.5 Max: 19.49
Current: 2.89
During the past 11 years, Sedana Medical AB's highest Current Ratio was 19.49. The lowest was 0.95. And the median was 9.50.
OSTO:SEDANA's Current Ratio is ranked better than 56.62% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs OSTO:SEDANA: 2.89
Sedana Medical AB (OSTO:SEDANA) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sedana Medical AB Current Ratio Related Terms
Sedana Medical AB Current Ratio Historical Data
* Premium members only.
The historical data trend for Sedana Medical AB's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SEDANA vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Sedana Medical AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sedana Medical AB Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sedana Medical AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sedana Medical AB (OSTO:SEDANA) has a Current Ratio of 2.89 as of Jun. 2026. This is 70% below median its historical median of 9.50. Over the past decade, Sedana Medical AB's Current Ratio has ranged from 0.95 to 19.49. According to the industry distribution chart, Sedana Medical AB ranks #370 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 43.4%.
Is Sedana Medical AB's Current Ratio too high?
Sedana Medical AB's current Current Ratio of 2.89 is 70% below median its 10-year median of 9.50. Over the past 10 years, this metric has ranged from a low of 0.95 to a high of 19.49. The Medical Devices & Instruments industry median Current Ratio is 2.49. Sedana Medical AB's value of 2.89 is 16.1% above this industry median. Based on the distribution chart, Sedana Medical AB ranks #370 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sedana Medical AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sedana Medical AB ranks #370 out of 853 companies for Current Ratio. This puts Sedana Medical AB in the upper half of its industry. The industry median Current Ratio is 2.49. Sedana Medical AB's value of 2.89 is 16.1% above this benchmark. Historically, Sedana Medical AB's own Current Ratio has ranged from 0.95 to 19.49 over the past decade. While the company's 10-year median is 9.50 vs. the industry median of 2.49, Sedana Medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sedana Medical AB's current Current Ratio of 2.89 is 16.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sedana Medical AB's current Current Ratio is 2.89, which is 70% below median its own 10-year median of 9.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Sedana Medical AB (OSTO:SEDANA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr17.42, compared to a current price of kr9.80 — trading 43.7% below its estimated fair value. The current Current Ratio is 2.89, which is 70% below median its 10-year median of 9.50 and 16.1% above the Medical Devices & Instruments industry median of 2.49. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sedana Medical AB (OSTO:SEDANA), the current Current Ratio is 2.89 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sedana Medical AB (OSTO:SEDANA) Overvalued in 2026?
Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued.
The current stock price of kr9.80 is trading 43.7% below its estimated GF Value™ of kr17.42.
GuruFocus considers Sedana Medical AB to be Significantly Undervalued.
Key valuation signals for OSTO:SEDANA:
Current Ratio: 2.89 (70% below median its 10-year median of 9.50)
GF Value™: kr17.42 vs. price of kr9.80 (43.7% below fair value)
Industry Position: 16.1% above the Medical Devices & Instruments median (#370 of 853)
No single metric tells the full story. See the OSTO:SEDANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score
Get the complete analysis for OSTO:SEDANA
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SEDANA has been successfully added to your 
